Literature DB >> 33947467

Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections.

Enas Fakhry Abdel-Hamed1, Mohamed N Ibrahim2, Nahed E Mostafa3, Howayda S F Moawad3, Nahla E Elgammal4, Ehab M Darwiesh4, Dina S El-Rafey5, Nissreen E ElBadawy6, Emad Ali Al-Khoufi7, Salwa I Hindawi8.   

Abstract

BACKGROUND: By 27 June 2020, almost half a million people had died due to COVID-19 infections. The susceptibility and severity of infection vary significantly across nations. The contribution of chronic viral and parasitic infections to immune homeostasis remains a concern. By investigating the role of interferon (IFN)-γ, we conducted this study to understand the connection between the decrease in numbers and severity of COVID-19 cases within parasitic endemic regions. Our research included 375 patients referred to hospitals for diagnosis of COVID-19 infection. Patients were subjected to full investigations, in particular severe acute respiratory syndrome coronavirus-2 nucleic acid and Toxoplasma IgM and IgG antibody detection, stool examination, and quantitative IFN-γ measurement.
RESULTS: The majority of the studied cases had chest manifestation either alone (54.7%) or in association with gastrointestinal (GIT) manifestations (19.7%), whereas 25.6% had GIT symptoms. We reported parasitic infections in 72.8% of mild COVID-19 cases and 20.7% of severe cases. Toxoplasma gondii, Cryptosporidium, Blastocyst, and Giardia were the most common parasitic infections among the COVID-19 cases studied.
CONCLUSION: The remarkable adaptation of human immune response to COVID-19 infection by parasitic infections with high levels of IFN-γ was observed in moderate cases compared with low levels in extreme cases. The potential therapeutic efforts aimed at the role of parasitic infection in immune system modulation are needed if this hypothesis is confirmed.

Entities:  

Year:  2021        PMID: 33947467     DOI: 10.1186/s13099-021-00427-3

Source DB:  PubMed          Journal:  Gut Pathog        ISSN: 1757-4749            Impact factor:   4.181


  23 in total

1.  Endolymphatic-mastoid shunt operation: results of the 24 cases and revision surgery with the silastic sheet.

Authors:  K Gyo; N Yanagihara
Journal:  Auris Nasus Larynx       Date:  1982       Impact factor: 1.863

2.  Does co-infection with Giardia lamblia modulate the clinical characteristics of enteric infections in young children?

Authors:  Natalya Bilenko; Amalya Levy; Ron Dagan; Richard J Deckelbaum; Yossef El-On; Drora Fraser
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

3.  The proinflammatory cytokine-induced IRG1 protein associates with mitochondria.

Authors:  Daniel Degrandi; Reinhard Hoffmann; Cornelia Beuter-Gunia; Klaus Pfeffer
Journal:  J Interferon Cytokine Res       Date:  2009-01       Impact factor: 2.607

4.  Dense Granule Protein-7 (GRA-7) of Toxoplasma gondii inhibits viral replication in vitro and in vivo.

Authors:  Prasanna Weeratunga; Thilina U B Herath; Tae-Hwan Kim; Hyun-Cheol Lee; Jae-Hoon Kim; Byeong-Hoon Lee; Eun-Seo Lee; Kiramage Chathuranga; W A Gayan Chathuranga; Chul-Su Yang; Jin Yeul Ma; Jong-Soo Lee
Journal:  J Microbiol       Date:  2017-10-27       Impact factor: 3.422

5.  Clinical and immunological features of severe and moderate coronavirus disease 2019.

Authors:  Guang Chen; Di Wu; Wei Guo; Yong Cao; Da Huang; Hongwu Wang; Tao Wang; Xiaoyun Zhang; Huilong Chen; Haijing Yu; Xiaoping Zhang; Minxia Zhang; Shiji Wu; Jianxin Song; Tao Chen; Meifang Han; Shusheng Li; Xiaoping Luo; Jianping Zhao; Qin Ning
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

6.  Critical adjustments in a department of orthopaedics through the COVID-19 pandemic.

Authors:  Gonzalo Luengo-Alonso; Fernando García-Seisdedos Pérez-Tabernero; Miguel Tovar-Bazaga; José Manuel Arguello-Cuenca; Emilio Calvo
Journal:  Int Orthop       Date:  2020-05-30       Impact factor: 3.075

Review 7.  The Immune System Can Hear Noise.

Authors:  Andi Zhang; Tianyuan Zou; Dongye Guo; Quan Wang; Yilin Shen; Haixia Hu; Bin Ye; Mingliang Xiang
Journal:  Front Immunol       Date:  2021-02-18       Impact factor: 7.561

Review 8.  The Dual Nature of Type I and Type II Interferons.

Authors:  Amanda J Lee; Ali A Ashkar
Journal:  Front Immunol       Date:  2018-09-11       Impact factor: 7.561

9.  Plasmodium co-infection protects against chikungunya virus-induced pathologies.

Authors:  Teck-Hui Teo; Fok-Moon Lum; Khairunnisa Ghaffar; Yi-Hao Chan; Siti Naqiah Amrun; Jeslin J L Tan; Cheryl Y P Lee; Tze-Kwang Chua; Guillaume Carissimo; Wendy W L Lee; Carla Claser; Ravisankar Rajarethinam; Laurent Rénia; Lisa F P Ng
Journal:  Nat Commun       Date:  2018-09-25       Impact factor: 14.919

10.  Failure in initial stage containment of global COVID-19 epicenters.

Authors:  Veria Khosrawipour; Hien Lau; Tanja Khosrawipour; Piotr Kocbach; Hirohito Ichii; Jacek Bania; Agata Mikolajczyk
Journal:  J Med Virol       Date:  2020-04-28       Impact factor: 20.693

View more
  4 in total

Review 1.  The Prevalence and Impact of Coinfection and Superinfection on the Severity and Outcome of COVID-19 Infection: An Updated Literature Review.

Authors:  Samya A Omoush; Jihad A M Alzyoud
Journal:  Pathogens       Date:  2022-04-07

2.  In vitro Screening of Herbal Medicinal Products for Their Supportive Curing Potential in the Context of SARS-CoV-2.

Authors:  Hoai Thi Thu Tran; Philipp Peterburs; Jan Seibel; D Abramov-Sommariva; Evelyn Lamy
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-06       Impact factor: 2.650

Review 3.  The Variable Nature of Vitamin C-Does It Help When Dealing with Coronavirus?

Authors:  Katarzyna Grudlewska-Buda; Natalia Wiktorczyk-Kapischke; Anna Budzyńska; Joanna Kwiecińska-Piróg; Jana Przekwas; Agnieszka Kijewska; Dominika Sabiniarz; Eugenia Gospodarek-Komkowska; Krzysztof Skowron
Journal:  Antioxidants (Basel)       Date:  2022-06-24

Review 4.  A role for T-cell exhaustion in Long COVID-19 and severe outcomes for several categories of COVID-19 patients.

Authors:  Kevin Roe
Journal:  J Neurosci Res       Date:  2021-07-19       Impact factor: 4.433

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.